- Home
- CNFR vs POAI Comparison
CNFR vs POAI Comparison
Compare CNFR & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNFR
- POAI
- Stock Information
- Founded
- CNFR 2009
- POAI 2002
- Country
- CNFR United States
- POAI United States
- Employees
- CNFR N/A
- POAI N/A
- Industry
- CNFR Property-Casualty Insurers
- POAI Industrial Specialties
- Sector
- CNFR Finance
- POAI Health Care
- Exchange
- CNFR Nasdaq
- POAI Nasdaq
- Market Cap
- CNFR 9.4M
- POAI 8.9M
- IPO Year
- CNFR 2015
- POAI N/A
- Fundamental
- Price
- CNFR $0.81
- POAI $0.79
- Analyst Decision
- CNFR
- POAI Hold
- Analyst Count
- CNFR 0
- POAI 1
- Target Price
- CNFR N/A
- POAI N/A
- AVG Volume (30 Days)
- CNFR 4.5K
- POAI 159.3K
- Earning Date
- CNFR 08-12-2025
- POAI 08-12-2025
- Dividend Yield
- CNFR N/A
- POAI N/A
- EPS Growth
- CNFR N/A
- POAI N/A
- EPS
- CNFR 1.96
- POAI N/A
- Revenue
- CNFR $64,021,000.00
- POAI $1,729,269.00
- Revenue This Year
- CNFR $25.91
- POAI $486.27
- Revenue Next Year
- CNFR N/A
- POAI $65.50
- P/E Ratio
- CNFR $0.41
- POAI N/A
- Revenue Growth
- CNFR N/A
- POAI 24.17
- 52 Week Low
- CNFR $0.42
- POAI $0.55
- 52 Week High
- CNFR $1.91
- POAI $3.06
- Technical
- Relative Strength Index (RSI)
- CNFR 44.32
- POAI 33.09
- Support Level
- CNFR $0.73
- POAI $0.73
- Resistance Level
- CNFR $0.81
- POAI $0.86
- Average True Range (ATR)
- CNFR 0.03
- POAI 0.05
- MACD
- CNFR -0.00
- POAI -0.00
- Stochastic Oscillator
- CNFR 21.66
- POAI 38.43
About CNFR Conifer Holdings Inc.
Conifer Holdings Inc is an insurance holding company. The company markets and services the product offerings of the company through specialty personal insurance business lines. The company offers insurance products in Texas, Illinois, and Indiana for homeowners lines and Nevada and Michigan for other lines. The revenues of the company are derived from premiums earned from insurance operations.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.